MILLENNIUM MANAGEMENT LLC bought SNSE
March 31, 2026 · Form 4 insider transaction
MILLENNIUM MANAGEMENT LLC bought 616 shares of SNSE at $24.69 per share, a transaction worth $15.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 45 days after the transaction.
Footnotes
Represents volume-weighted average price ("VWAP") of purchases of 616 shares of common stock ("Common Stock"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the "Company") on March 31, 2026 at prices ranging from $23.91 to $24.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein.; In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2.; The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any.